Abstract:
The present disclosure relates to systems and methods for explosive systems such as grenades with novel micro-electromechanical systems (MEMS) fuze and novel placement of the MEMS fuze providing increased performance, reliability, and safety. The MEMS fuze is disposed towards a rear portion of the explosive system providing superior performance and design flexibility. Further, the explosive system includes electronics configured to implement a launch timer and to sense impact or when the system stops spinning. The present invention includes an operational method improving safety and reliability by preventing detonation until after the launch timer expires, upon impact, or when the explosive system stops spinning.
Abstract:
The output current of a fixed-frequency DC to DC converter is sensed, creating a voltage representative of the load current. This voltage is then compared to one or more threshold voltages using a plurality of comparators, creating a plurality of logic signals indicative of which of a plurality of ranges the output current falls within. These logic signals are coupled to a multiplexer which decodes the logical inputs to one-of-n and selects one gate drive voltage from a plurality of such voltages, each optimized for its corresponding current range. The selected gate drive voltage is then used as the gate drive in a known art DC to DC converter, thereby increasing efficiency over a wide range of output current.
Abstract:
Presently described are microstructured articles such as a brightness enhancing film or optical turning film. The microstructured articles comprise a brightness enhancing polymerized structure comprising the reaction product of a composition comprising an organic component having at least one oligomeric urethane (meth)acrylate and surface modified silica nanoparticles.
Abstract:
External power source, charger, system and method for an implantable medical device having therapeutic componentry and a secondary coil operatively coupled to the therapeutic componentry. A primary charging coil is capable of transcutaneously inductively energizing the secondary coil when externally placed in proximity of the secondary coil. Drive circuitry is operatively coupled to the primary charging coil for exciting the primary charging coil. A rechargeable power source is operatively coupled to the drive circuitry. A secondary recharging coil is operatively coupled to the rechargeable power source. A primary recharging coil is adapted to be coupled to a source of AC power which when placed in proximity of the secondary recharging coil can inductively energize the secondary recharging coil in order to charge the rechargeable power source.
Abstract:
A transistor has an emitter, a spin-selective base, a collector, a first barrier interposed between the spin-selective base and the emitter, a second barrier interposed between the spin-selective base and the collector, and a transfer ratio of more than 10−3.
Abstract:
External energy source, external charger, system of transcutaneous energy transfer, system of transcutaneous charging and method thereof. An implantable medical device has a secondary coil operatively coupled to therapeutic componentry. An external power source has a housing, a primary coil carried in the housing with the primary coil being capable of inductively energizing the secondary coil when the housing is externally placed in proximity of the secondary coil with a first surface of the housing positioned closest to the secondary coil and a thermo-electric cooling device placed associated with the first surface of the housing.
Abstract:
Microstructured optical films, assemblies of films including at least one microstructured optical film, and (e.g. illuminated) display devices including a single microstructured optical film or assembly.
Abstract:
The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
Abstract:
The present invention relates to a fluid treatment system comprising: an inlet; an outlet; and a fluid treatment zone disposed between the inlet and the outlet. The fluid treatment zone has disposed therein: (i) an elongate first radiation source assembly having a first longitudinal axis, and (ii) an elongate second radiation source assembly having a second longitudinal axis. The first longitudinal axis and the second longitudinal axis are non-parallel to each other and to a direction of fluid flow through the fluid treatment zone. The present fluid treatment system has a number of advantages including: it can treat large volumes of fluid (e.g., wastewater, drinking water or the like); it requires a relatively small “footprint”; it results in a relatively lower coefficient of drag resulting in an improved hydraulic pressure loss/gradient over the length of the fluid treatment system; and it results in relatively lower (or no) forced oscillation of the radiation sources thereby obviating or mitigating of breakage of the radiation source and/or protective sleeve (if present). Other advantages are discussed in the specification.